Nestle logo

Nestle

Last updated January 31, 2026
125
Innovation Areas
3,230
Inventors
16
Collaborations

Gramineous fiber fermentation substrates: NestleRecent Research Landscape

Live probiotic instability leads to inconsistent therapeutic dosing and short shelf life. Engineering specific non-viable metabolic byproducts ensures bioactive consistency and product stability.

What technical problems is Nestle addressing in Gramineous fiber fermentation substrates?

Inefficient intestinal microbial colonization

(9)evidences

Neonatal microbiomes often lack the metabolic versatility to process both maternal and solid food carbohydrate sources simultaneously. Establishing early microbial dominance prevents pathogenic infiltration and supports developmental nutrition.

Insoluble fiber fermentability resistance

(9)evidences

Insufficient secretory immunoglobulin production and disrupted gut-brain axis signaling. Restoring these biological functions mitigates systemic inflammation and neurological symptoms.

Insufficient commensal bacteria proliferation

(2)evidences

Low natural growth rates of Faecalibacterium prausnitzii limit its therapeutic efficacy in the gut. Overcoming this growth bottleneck increases the production of anti-inflammatory metabolites and proteins like Serpin.